Laboratory Of America Holdings Stock News

Investors are optimistic about LabCorp (LH) backed by consistent recovery across its businesses and raised 2021 guidance.

Expanded Facility Provides Comprehensive Capabilities to Support Global Pharmaceutical Drug Development Programs SINGAPORE , Nov. 15, 2021 /PRNewswire/ -- Labcorp (NYSE: LH), a leading global life sciences company, today announced the expansion of its global offerings and its footprint in the Asia-Pacific (APAC) region with the opening of a new, integrated bioanalytical laboratory in Singapore . The laboratory features new capabilities that enhance the substantial array of bioanalytical services currently offered through Labcorp Drug Development , allowing the company to meet increased demand from pharmaceutical and biotechnology companies. " Singapore serves as a strategic location from which Labcorp can increase accessibility by offering regional and international clients comprehensive support for their bioanalytical studies," said Dr. Paul Kirchgraber , CEO of Labcorp Drug Development. "With this expansion, the company is advancing its position as a life science leader in the region and across the globe.

Hall Laurie J Trustee lowered its stake in Laboratory Co. of America Holdings (NYSE:LH) by 11.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,065 shares of the medical research companys stock after selling 135 shares during the period. Hall Laurie J Trustees holdings []

Laboratory Corp of America Holdings (NYSE: LH) is in talks to combine some of its assets with Syneos Health Inc (NASDAQ: SYNH), reports Bloomberg citing people with knowledge of the matter.  The

These top-ranked stocks are likely to beat on the bottom line in their next releases.

LH vs. COO: Which Stock Is the Better Value Option?

LabCorp (LH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Laboratory Corporation of America Holdings (LH) CEO Adam Schechter on Q3 2021 Results - Earnings Call Transcript

LabCorp (LH) delivered earnings and revenue surprises of 42.98% and 13.53%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

LabCorp (LH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

LH vs. ALGN: Which Stock Is the Better Value Option?

LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The FDA has granted Emergency Use Authorization (EUA) to Laboratory Corp of America Holdings's (NYSE: LH) combined home collection kit to detect COVID-19 and influenza A/B simultaneously in individu

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administra